Immuron (IMRN) Total Liabilities (2016 - 2025)
Immuron's quarterly Total Liabilities came in at $20607.9 in Q3 2025, down 27.45% year-on-year from $28405.2 in Q3 2024, and down 98.44% quarter-over-quarter from $1.3 million in Q2 2025.
Immuron has reported Total Liabilities for 10 years, with the latest figure at $20607.9 in Q3 2025.
- For the quarter ending Q3 2025, Total Liabilities fell 27.45% year-over-year to $20607.9; the trailing twelve-month figure through Sep 2025 stood at $20607.9 (down 27.45% YoY), and the FY2025 full-year result was $20607.9, down 27.45% from the prior year.
- Total Liabilities for Q3 2025 stood at $20607.9, down from $1.3 million in the prior quarter.
- The five-year high for Total Liabilities was $1.9 million in Q2 2024, with the low at $11580.5 in Q2 2021.
- Average Total Liabilities over 5 years is $768428.2, with a median of $973200.0 recorded in 2021.
- Year-over-year, Total Liabilities surged 16029.2% in 2021 and slumped 98.61% in 2023.
- Tracing IMRN's Total Liabilities over 5 years: stood at $843639.5 in 2021, then surged by 30.71% to $1.1 million in 2022, then tumbled by 98.61% to $15338.6 in 2023, then surged by 7703.14% to $1.2 million in 2024, then plunged by 98.28% to $20607.9 in 2025.
- The last three Total Liabilities figures came in at $20607.9 (Q3 2025), $1.3 million (Q2 2025), and $1.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | 20,607.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 20,607.86 |
| Jun 30, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 9, 2024 | 28,405.25 |
| Jun 30, 2024 | 1.87 Mn |
| Dec 31, 2023 | 15,338.64 |
| Sep 28, 2023 | 1.55 Mn |
| Aug 30, 2023 | 23,713.46 |
| Jun 30, 2023 | 1.58 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Aug 31, 2022 | 1.17 Mn |
| Jun 30, 2022 | 16,784.23 |
| Dec 31, 2021 | 843,639.55 |
| Jun 30, 2021 | 11,580.49 |
| Dec 31, 2020 | 5,230.51 |
| Sep 1, 2020 | 558,250.00 |
| Jun 30, 2020 | 365,888.56 |
| Dec 31, 2019 | 5.58 Bn |
| Jun 30, 2019 | 847,929.39 |
| Dec 31, 2018 | 521,234.00 |
| Sep 27, 2018 | 587,944.04 |
| Aug 30, 2018 | 803,338.00 |
| Jun 30, 2018 | 608,156.52 |
| Dec 31, 2017 | 1.33 Mn |
| Sep 28, 2017 | 1.35 Mn |
| Aug 31, 2017 | 1.71 Mn |
| Jun 30, 2017 | 1.29 Mn |
| Dec 31, 2016 | 2.93 Mn |
| Jun 30, 2016 | 2.90 Mn |